Shanghai Pharmaceuticals Holding Co., Ltd (SHPMF)
USD 1.27
(0.0%)
USD 1.27
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 131.64 Billion CNY | 9.58% |
| 2022 | 120.13 Billion CNY | 15.1% |
| 2021 | 104.36 Billion CNY | 10.51% |
| 2020 | 94.44 Billion CNY | 7.76% |
| 2019 | 87.64 Billion CNY | 8.94% |
| 2018 | 80.44 Billion CNY | 47.15% |
| 2017 | 54.66 Billion CNY | 19.08% |
| 2016 | 45.9 Billion CNY | 13.25% |
| 2015 | 40.53 Billion CNY | 21.94% |
| 2014 | 33.24 Billion CNY | 21.72% |
| 2013 | 27.31 Billion CNY | 16.87% |
| 2012 | 23.36 Billion CNY | 7.76% |
| 2011 | 21.68 Billion CNY | 33.17% |
| 2010 | 16.28 Billion CNY | 157.08% |
| 2009 | 6.33 Billion CNY | 11.8% |
| 2008 | 5.66 Billion CNY | 9.65% |
| 2007 | 5.16 Billion CNY | 12.05% |
| 2006 | 4.61 Billion CNY | 5.53% |
| 2005 | 4.37 Billion CNY | -0.75% |
| 2004 | 4.4 Billion CNY | 9.33% |
| 2003 | 4.02 Billion CNY | 18.34% |
| 2002 | 3.4 Billion CNY | 37.51% |
| 2001 | 2.47 Billion CNY | -2.94% |
| 2000 | 2.54 Billion CNY | 15.61% |
| 1999 | 2.2 Billion CNY | 16.23% |
| 1998 | 1.89 Billion CNY | 518.28% |
| 1997 | 306.94 Million CNY | -1.92% |
| 1996 | 312.95 Million CNY | 17.26% |
| 1995 | 266.87 Million CNY | 18.53% |
| 1994 | 225.15 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q3 | 140.58 Billion CNY | 1.47% |
| 2024 Q2 | 138.54 Billion CNY | 2.38% |
| 2024 Q1 | 135.33 Billion CNY | 2.8% |
| 2023 FY | 131.64 Billion CNY | 9.58% |
| 2023 Q2 | 134.37 Billion CNY | 6.52% |
| 2023 Q1 | 126.15 Billion CNY | 5.01% |
| 2023 Q3 | 133 Billion CNY | -1.02% |
| 2023 Q4 | 131.64 Billion CNY | -1.02% |
| 2022 Q3 | 118 Billion CNY | 5.9% |
| 2022 Q1 | 107.64 Billion CNY | 3.14% |
| 2022 FY | 120.13 Billion CNY | 15.1% |
| 2022 Q2 | 111.43 Billion CNY | 3.52% |
| 2022 Q4 | 120.13 Billion CNY | 1.81% |
| 2021 Q1 | 99.29 Billion CNY | 5.14% |
| 2021 Q4 | 104.36 Billion CNY | -0.77% |
| 2021 Q3 | 105.17 Billion CNY | 4.0% |
| 2021 Q2 | 101.13 Billion CNY | 1.85% |
| 2021 FY | 104.36 Billion CNY | 10.51% |
| 2020 Q1 | 89.89 Billion CNY | 2.57% |
| 2020 FY | 94.44 Billion CNY | 7.76% |
| 2020 Q2 | 96.13 Billion CNY | 6.95% |
| 2020 Q3 | 95.44 Billion CNY | -0.72% |
| 2020 Q4 | 94.44 Billion CNY | -1.05% |
| 2019 Q4 | 87.64 Billion CNY | 0.88% |
| 2019 Q2 | 86.07 Billion CNY | -0.47% |
| 2019 Q1 | 86.48 Billion CNY | 7.5% |
| 2019 FY | 87.64 Billion CNY | 8.94% |
| 2019 Q3 | 86.87 Billion CNY | 0.93% |
| 2018 Q3 | 78.77 Billion CNY | 5.13% |
| 2018 Q1 | 70.2 Billion CNY | 28.42% |
| 2018 FY | 80.44 Billion CNY | 47.15% |
| 2018 Q4 | 80.44 Billion CNY | 2.12% |
| 2018 Q2 | 74.93 Billion CNY | 6.73% |
| 2017 Q4 | 54.66 Billion CNY | 3.01% |
| 2017 FY | 54.66 Billion CNY | 19.08% |
| 2017 Q1 | 50.94 Billion CNY | 10.97% |
| 2017 Q2 | 52.68 Billion CNY | 3.42% |
| 2017 Q3 | 53.06 Billion CNY | 0.72% |
| 2016 Q3 | 44.99 Billion CNY | 2.37% |
| 2016 FY | 45.9 Billion CNY | 13.25% |
| 2016 Q4 | 45.9 Billion CNY | 2.02% |
| 2016 Q2 | 43.95 Billion CNY | 2.8% |
| 2016 Q1 | 42.75 Billion CNY | 5.49% |
| 2015 Q2 | 37.91 Billion CNY | 7.26% |
| 2015 Q4 | 40.53 Billion CNY | 1.91% |
| 2015 Q3 | 39.77 Billion CNY | 4.9% |
| 2015 Q1 | 35.35 Billion CNY | 6.35% |
| 2015 FY | 40.53 Billion CNY | 21.94% |
| 2014 Q2 | 33.36 Billion CNY | 16.35% |
| 2014 Q4 | 33.24 Billion CNY | -3.21% |
| 2014 Q3 | 34.34 Billion CNY | 2.94% |
| 2014 FY | 33.24 Billion CNY | 21.72% |
| 2014 Q1 | 28.67 Billion CNY | 5.0% |
| 2013 Q3 | 26.53 Billion CNY | 1.02% |
| 2013 FY | 27.31 Billion CNY | 16.87% |
| 2013 Q4 | 27.31 Billion CNY | 2.93% |
| 2013 Q2 | 26.26 Billion CNY | 7.17% |
| 2013 Q1 | 24.5 Billion CNY | 4.88% |
| 2012 Q1 | 22.67 Billion CNY | 4.54% |
| 2012 Q3 | 23.77 Billion CNY | -0.13% |
| 2012 Q4 | 23.36 Billion CNY | -1.72% |
| 2012 FY | 23.36 Billion CNY | 7.76% |
| 2012 Q2 | 23.8 Billion CNY | 5.01% |
| 2011 Q4 | 21.68 Billion CNY | -4.5% |
| 2011 Q3 | 22.7 Billion CNY | 13.72% |
| 2011 FY | 21.68 Billion CNY | 33.17% |
| 2011 Q2 | 19.96 Billion CNY | 4.9% |
| 2011 Q1 | 19.03 Billion CNY | 16.89% |
| 2010 Q3 | 14.72 Billion CNY | 9.61% |
| 2010 Q4 | 16.28 Billion CNY | 10.56% |
| 2010 FY | 16.28 Billion CNY | 157.08% |
| 2010 Q1 | 13.18 Billion CNY | 108.19% |
| 2010 Q2 | 13.43 Billion CNY | 1.89% |
| 2009 Q3 | 6.91 Billion CNY | 7.5% |
| 2009 Q1 | 6.37 Billion CNY | 12.49% |
| 2009 Q2 | 6.42 Billion CNY | 0.86% |
| 2009 Q4 | 6.33 Billion CNY | -8.33% |
| 2009 FY | 6.33 Billion CNY | 11.8% |
| 2008 Q2 | 5.99 Billion CNY | 0.72% |
| 2008 Q1 | 5.95 Billion CNY | 15.28% |
| 2008 FY | 5.66 Billion CNY | 9.65% |
| 2008 Q4 | 5.66 Billion CNY | -7.25% |
| 2008 Q3 | 6.1 Billion CNY | 1.81% |
| 2007 Q1 | 4.9 Billion CNY | 6.34% |
| 2007 Q3 | 5.35 Billion CNY | 5.88% |
| 2007 Q2 | 5.05 Billion CNY | 3.16% |
| 2007 Q4 | 5.16 Billion CNY | -3.53% |
| 2007 FY | 5.16 Billion CNY | 12.05% |
| 2006 Q1 | 4.86 Billion CNY | 11.36% |
| 2006 Q4 | 4.61 Billion CNY | -1.57% |
| 2006 Q3 | 4.68 Billion CNY | -0.86% |
| 2006 Q2 | 4.72 Billion CNY | -2.9% |
| 2006 FY | 4.61 Billion CNY | 5.53% |
| 2005 FY | 4.37 Billion CNY | -0.75% |
| 2005 Q4 | 4.37 Billion CNY | -14.9% |
| 2005 Q2 | 5.1 Billion CNY | -2.98% |
| 2005 Q3 | 5.13 Billion CNY | 0.56% |
| 2005 Q1 | 5.26 Billion CNY | 19.53% |
| 2004 Q4 | 4.4 Billion CNY | -12.61% |
| 2004 FY | 4.4 Billion CNY | 9.33% |
| 2004 Q1 | 4.54 Billion CNY | 12.9% |
| 2004 Q2 | 4.39 Billion CNY | -3.29% |
| 2004 Q3 | 5.03 Billion CNY | 14.58% |
| 2003 Q3 | 3.94 Billion CNY | 3.87% |
| 2003 Q2 | 3.8 Billion CNY | 0.87% |
| 2003 Q1 | 3.76 Billion CNY | 10.73% |
| 2003 FY | 4.02 Billion CNY | 18.34% |
| 2003 Q4 | 4.02 Billion CNY | 2.0% |
| 2002 Q3 | 3.45 Billion CNY | 3.68% |
| 2002 Q1 | 2.97 Billion CNY | 20.24% |
| 2002 FY | 3.4 Billion CNY | 37.51% |
| 2002 Q2 | 3.33 Billion CNY | 12.13% |
| 2002 Q4 | 3.4 Billion CNY | -1.63% |
| 2001 Q2 | 1.95 Billion CNY | 0.0% |
| 2001 FY | 2.47 Billion CNY | -2.94% |
| 2001 Q4 | 2.47 Billion CNY | 0.0% |
| 2000 Q2 | 2.59 Billion CNY | 0.0% |
| 2000 Q4 | 2.54 Billion CNY | 0.0% |
| 2000 FY | 2.54 Billion CNY | 15.61% |
| 1999 FY | 2.2 Billion CNY | 16.23% |
| 1999 Q2 | 1.91 Billion CNY | 0.0% |
| 1999 Q4 | 2.2 Billion CNY | 0.0% |
| 1998 FY | 1.89 Billion CNY | 518.28% |
| 1997 FY | 306.94 Million CNY | -1.92% |
| 1997 Q2 | 252.52 Million CNY | 0.0% |
| 1997 Q4 | 306.94 Million CNY | 0.0% |
| 1996 FY | 312.95 Million CNY | 17.26% |
| 1996 Q4 | 312.95 Million CNY | 0.0% |
| 1996 Q2 | 281 Million CNY | 0.0% |
| 1995 Q2 | 230.88 Million CNY | 0.0% |
| 1995 FY | 266.87 Million CNY | 18.53% |
| 1995 Q4 | 266.87 Million CNY | 0.0% |
| 1994 Q4 | 225.15 Million CNY | 0.0% |
| 1994 FY | 225.15 Million CNY | 0.0% |
| 1994 Q2 | 190.96 Million CNY | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| China Medicine Corporation | 21.33 Million USD | -616930.313% |
| DH Enchantment Inc. | 989.77 Thousand USD | -13300502.842% |
| Exlites Holdings International, Inc. | 33.75 Thousand USD | -390051871.204% |
| Itonis, Inc. | 1.14 Million USD | -11476457.271% |
| One Step Vending Corp. | 465.73 Thousand USD | -28266222.724% |
| MediPal Holdings Corporation | 7.02 Billion USD | -1775.299% |
| PD-Rx Pharmaceuticals, Inc. | 1.69 Million USD | -7756565.716% |
| Pharmagen, Inc. | 8868.81 USD | -1484375377.668% |
| Suzuken Co., Ltd. | 5.36 Billion USD | -2353.081% |